Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
Third quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $33.3 million ---- Adult patients with acquired hypothalamic ...
Marshall Monitor III ANC
It's easy to take the Monitor III ANC with you on the road. The earcups swivel, fold up, and stack atop each other, allowing the headphones to fit into the small hard case supplied. The case is thick ...
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...